Skip to main content

Expert opinion

Free registration

Medicine Matters is developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.


Concise and thought-provoking commentary, opinion and analysis from diabetes practitioners and researchers.


Tirzepatide: A new challenger for type 2 diabetes management?

What does the future hold for the novel agent tirzepatide, a GIP/GLP-1 co-agonist? John Wilding examines what we know so far.

Balancing pros and cons

06-05-2020 | Type 2 diabetes | Editorial | Article

Oral semaglutide: A technical triumph, with caveats

Diabetologist and Editorial Board member John Wilding gives his opinion on the latest addition to the GLP-1RA class, oral semaglutide.

New Year transition

03-03-2020 | Guidelines | Editorial | Article

Standards of Medical Care in Diabetes: A 2020 Update from the American Diabetes Association

Sanjay Kalra, Diabetologist and Editorial Board member, outlines what's new in the American Diabetes Association’s 2020 Standards of Care update. 

A selection of KwikPens from Lilly Diabetes

17-12-2019 | Insulin | Editorial | Article

How can we optimize titration with new basal insulins?

Nurse and Diabetes Educator Lori Berard highlights the advantages of “concentrated” insulins and outlines her recommendations for getting titration right for patients.

Mother helps son check blood sugar

29-10-2019 | Diabetes prevention | Editorial | Article

The family and diabetes care: A multifaceted relationship

Before attention turns to World Diabetes Day 2019, Sanjay Kalra revisits 2018’s theme to evaluate the concerns and opportunities presented by “The Family and Diabetes”.

Nutrition therapy for diabetes: A marathon, not a sprint

10-09-2019 | Diet | Editorial | Article

Nutrition therapy for diabetes: A marathon, not a sprint

What's new in the 2019 update to the ADA guidelines on nutrition therapy for adults with diabetes or prediabetes? Diabetes Educator Amy Hess Fischl explains.

Cardiorenal syndromes and SGLT2 inhibitor usage

06-08-2019 | SGLT2 inhibitors | Editorial | Article

Cardiorenal syndromes and SGLT2 inhibitor usage

Sanjay Kalra explores the intrinsic link between the cardiovascular and renal systems, focusing on whether the SGLT2 inhibitor class has a role to play in diabetic patients with cardiorenal comorbidity.

Sulfonylurea pill

22-05-2019 | Sulfonylureas | Editorial | Article

The CAROLINA trial: Make or break for sulfonylureas?

Diabetologist Sanjay Kalra puts the CAROLINA trial into historical context and considers the present-day implications for the use of DPP-4 inhibitors and sulfonylureas.

Exposure to diabetes technologies: Where now for adult services?

03-05-2019 | Devices and technology | Editorial | Article

Exposure to diabetes technologies: Where now for adult services?

What does the proliferation of diabetes self-management and monitoring technologies in pediatric care mean for the future of adult services? Katharine Barnard looks at the situation in England and Wales.

Diabetes and dementia: Addressing the needs of an overlooked population

04-03-2019 | Mental health | Editorial | Article

Diabetes and dementia: Addressing the needs of an overlooked population

Diabetologist Amar Puttanna addresses growing concerns about the rise of dementia in diabetes care and highlights where guidelines, research efforts, and management options are needed to tackle this comorbidity.

Sleep apnea (symbolic image with model)

14-12-2018 | Sleep apnea | Editorial | Article

Diabetes and obstructive sleep apnea syndrome: Double trouble

Obstructive sleep apnea syndrome is a common and potentially serious comorbidity in people with diabetes and obesity. John Wilding highlights what you need to know about the condition.

Dictionary

05-12-2018 | Diabetes distress | Editorial | Article

Diabetes distress: What’s in a name?

Sanjay Kalra and Psychiatrist Yatan Pal Singh Balhara question whether “diabetes distress” is well understood outside of the diabetes field and consider whether alternative terminology may help to bridge the knowledge gap.

Medication arranged in a heart shape

14-11-2018 | Cardiovascular outcomes | Editorial | Article

What have I learned from cardiovascular outcome trials?

Endocrinologist Sanjay Kalra considers the impact that cardiovascular outcome trials have had on the standard of diabetes care and questions what else they might accomplish in the future.

Woman checking blood sugar level while lying in bedroom

24-10-2018 | Diabetes distress | Editorial | Article

Feeling stressed out and not meeting goals: A vicious cycle impacting diabetes self-management

Clinical psychologists Diana Naranjo and Korey Hood tackle the negative feedback loops that can develop around diabetes self-management and offer their insights on strategies to identify and address the roots of distress.

12-09-2018 | Diet | Commentary | Article

Diet–drug interactions: Why two rights can make a wrong

Editorial Board member and Endocrinologist, Sanjay Kalra comments on the issues raised by a clinical case involving sodium glucose cotransporter 2 inhibitor therapy alongside a restrictive diet.

Ambulatory glucose profile

29-08-2018 | Blood glucose monitoring | Editorial | Article

The ambulatory glucose profile: What, why, and how?

Editorial Board member Lori Berard discusses how the ambulatory glucose profile is quietly revolutionizing the analysis of blood glucose and glycemic control for patients and practitioners.

Shared decision-making

22-08-2018 | Psychosocial care | Editorial | Article

Shared decision-making in patient-centered care

Is the medical model of care failing diabetes patients in its current form? Advisory Board member Katharine Barnard considers this, and the future of clinical decision support.

Diabetic foot test (symbolic image with models)

15-08-2018 | Neuropathy | Editorial | Article

Are we using the right tests to diagnose diabetic neuropathy?

Uazman Alam and colleagues interrogate current evidence and real-world clinical scenarios to address whether enough is being done with the tools available to screen and diagnose diabetic neuropathy.

AdobeStock_64823908

24-07-2018 | Devices and technology | Editorial | Article

The right device at the right time: Optimizing the benefit

Advisory Board member Katharine Barnard scrutinizes the opinion that clinicians should be relying on glycemic outcomes when weighing the decision to prescribe a diabetes device.

Tackling clinical inertia: The role of patient engagement

16-07-2018 | Quality of life | Editorial | Article

Tackling clinical inertia: The role of patient engagement

Carmen Soto and David Strain provide their insights on clinical inertia in diabetes care and present the co-production model of open communication as an innovative means to address this widespread clinical issue.

Stethoscope and map

30-05-2018 | Insulin | Editorial | Article

Hit early, hit hard: The EADSG insulin guidelines

Sanjay Kalra and Silver Bahendeka, East Africa Diabetes Study Group Chair, provide an overview of the latest insulin guidance developed to aid management in a challenging region, facing familiar struggles.